Heart, Lung and Circulation
Volume 16, Issue 4 , Pages 269-273 , August 2007

Contemporary Treatment of In-Stent Restenosis and the Incidence of Recurrent In-Stent Restenosis in the Era of Drug-Eluting Stents

  • Andrew E. Ajani, FRACP, MD, FJFICM

      Affiliations

    • Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia
    • National Health Medical Research Council, Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: Department of Cardiology, Royal Melbourne Hospital, Grattan Street, Parkville 3050, Australia. Tel.: +61 3 9347 0499; fax: +61 3 9347 6760.
    • ,
  • Bryan P. Yan, FRACP

      Affiliations

    • Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia
    • ,
  • David J. Clark, FRACP

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Australia
    • ,
  • David Eccleston, MMed Sci, FRACP

      Affiliations

    • Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia
    • ,
  • Anthony Walton, FRACP

      Affiliations

    • Department of Cardiology, Alfred Hospital, Melbourne, Australia
    • ,
  • Robert Lew, FRACP, PhD

      Affiliations

    • Department of Cardiology, Frankston Hospital, Melbourne, Australia
    • ,
  • Adam Meehan

      Affiliations

    • National Health Medical Research Council, Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • ,
  • Angela Brennan, RN

      Affiliations

    • National Health Medical Research Council, Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • ,
  • Chris Reid, PhD

      Affiliations

    • National Health Medical Research Council, Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • ,
  • Stephen J. Duffy, FRACP, PhD

      Affiliations

    • Department of Cardiology, Alfred Hospital, Melbourne, Australia
    • ,
  • On behalf of the Melbourne Interventional Group (MIG) Investigators

Received 16 January 2006 ,Revised 8 February 2007 ,Accepted 11 February 2007.

References 

  1. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol. 2002;39(2):183–193
  2. Radke PW, Kaiser A, Frost C, Sigwart U. Outcome after treatment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques. Eur Heart J. 2003;24(3):266–273
  3. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–1323
  4. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–231
  5. Waksman R, Bhargava B, White L, Chan RC, Mehran R, Lansky AJ, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation. 2000;101(16):1895–1898
  6. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation. 2000;101(18):2165–2171
  7. Holmes DR, Teirstein P, Satler L, Sketch M, O’Malley J, Popma JJ, et al. SISR Investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295(11):1264–1273
  8. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, et al. TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006;295(11):1253–1263
  9. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti V, Lopez-Minguez JR, et al. RIBS-II Investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol. 2006;47(11):2152–2160
  10. Yan BPY, Ajani AE, Waksman R. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review. Cardiovasc Revascularization Med. 2005;6:38–43
  11. Ajani AE, Szto G, Duffy SJ, Eccleston D, Clark DJ, Lefkovits J, et al. Melbourne Interventional Group investigators. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ. 2006;15(1):44–47
  12. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100(18):1872–1878
  13. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293(2):165–171
  14. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003;108(3):257–260
  15. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 2002;106(21):2649–2651
  16. Sianos G, Hofma S, Ligthart JM, Saia F, Hoye A, Lemos PA, et al. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv. 2004;61(1):111–116
  17. Takebayashi H, Kobayashi Y, Dangas G, Fujii K, Mintz GS, Stone GW, et al. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv. 2003;60(4):496–499
  18. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation. 2005;111(17):2257–2273
  19. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation. 2003;107(17):2178–2180
  20. Lemos PA, van Mieghem CA, Arampatzis CA, Hoye A, Ong AT, McFadden E, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation. 2004;109(21):2500–2502
  21. Waters RE, Kandzari DE, Phillips HR, Crawford LE, Sketch MH. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv. 2005;65(4):520–524
  22. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364(9444):1519–1521
  23. Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, et al. CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2411–2420
  24. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358(9281):527–533

PII: S1443-9506(07)00130-8

doi: 10.1016/j.hlc.2007.02.089

Heart, Lung and Circulation
Volume 16, Issue 4 , Pages 269-273 , August 2007

Article Tools

* Image Usage & Resolution